Literature DB >> 627837

Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection.

M W Verbonitz, F A Ennis, J T Hicks, P Albrecht.   

Abstract

The host defense response to influenza infection is complex. Specific humoral antibodies develop to the strain-specific surface antigens, the hemagglutinin and the neuraminidase, and to the internal antigens (matrix and nucleoprotein) which are common to all influenza A viruses (1). Antibodies to the hemagglutinin, which is the major surface antigen, neutralize viral infectivity (2). In addition to antibodies which have been detected against virion antigens, a cytotoxic T-cell response with specificity against the viral hemagglutinin on influenza-infected target cells (3-5) has been recently described. A more cross-reactive cytotoxic T-cell response has also been observed when a nonpermissively infected target cell is used in cytotoxicity assays (6,7). The present report describes the development during influenza infection and after vaccination of a cytolytic humoral antibody response which is directed against the hemagglutinin on infected target cells. This antibody-mediated lysis of infected cells in complement dependent, as has been reported with other virus infections (8-11).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627837      PMCID: PMC2184088          DOI: 10.1084/jem.147.1.265

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  Effect of various methods of removing non-specific inhibitors to virus hemagglutination upon serum proteins and immunoglobulins.

Authors:  N M Tauraso; F A Pedreira; S L Spector; G M Bernier
Journal:  Arch Gesamte Virusforsch       Date:  1971

3.  Plaque formation by influenza viruses in the presence of trypsin.

Authors:  G Appleyard; H B Maber
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

4.  Inhibition or enhancement of immunological injury of virus-infected cells.

Authors:  A M Brier; C Wohlenberg; J Rosenthal; M Mage; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

5.  Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system.

Authors:  M B Oldstone; F J Dixon
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

6.  Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.

Authors:  J T Hicks; M J Klutch; P Albrecht; M M Frank
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

7.  Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.

Authors:  F A Ennis; W J Martin; M W Verbonitz; G M Butchko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

8.  Hemagglutinin-specific cytotoxic T-cell response during influenza infection.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  Leukotactic factors elaborated by virus-infected tissues.

Authors:  P A Ward; S Cohen; T D Flanagan
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

View more
  14 in total

1.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 2.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

3.  Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.

Authors:  Felix W Santiago; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

4.  Passive immunization with influenza haemagglutinin specific monoclonal antibodies.

Authors:  Rajeev Rudraraju; Kanta Subbarao
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

5.  Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

Authors:  Masanori Terajima; John Cruz; Mary Dawn T Co; Jane-Hwei Lee; Kaval Kaur; Jens Wrammert; Patrick C Wilson; Francis A Ennis
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.

Authors:  C R Lambre; M Thibon; S Le Maho; G Di Bella
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

7.  Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.

Authors:  G V Quinnan; F A Ennis; C U Tuazon; M A Wells; G M Butchko; R Armstrong; C McLaren; J F Manischewitz; S Kiley
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

8.  Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro.

Authors:  M A Wells; P Albrecht; S Daniel; F A Ennis
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus.

Authors:  F A Ennis; A Meager
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

Authors:  Rachael Keating; Tomer Hertz; Marie Wehenkel; Tarsha L Harris; Benjamin A Edwards; Jennifer L McClaren; Scott A Brown; Sherri Surman; Zachary S Wilson; Philip Bradley; Julia Hurwitz; Hongbo Chi; Peter C Doherty; Paul G Thomas; Maureen A McGargill
Journal:  Nat Immunol       Date:  2013-10-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.